An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis

Journal of Pineal Research

Volumn 46, Issue 3, 2009, Pages 262-267

  Tajes Orduña, Marta ^b   Pelegrí Gabalda, Carme ^b   Vilaplana Hortensi, Jordi ^b   Pallàs Lliberia, Mercè ^b   Camins Espuny, Antoni ^a,b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Aging; Cell cycle; Neurodegeneration; P53

Indexed keywords

CYCLIN D; DNA; MELATONIN; PROTEIN KINASE B; PROTEIN P53; TRANSCRIPTION FACTOR E2F1;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CELL COUNT; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA DAMAGE; EXPERIMENTAL MODEL; IN VITRO STUDY; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL AGING; CELLS, CULTURED; CEREBELLUM; CYCLINS; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; GLYCOGEN SYNTHASE KINASE 3; MELATONIN; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 62449146689     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00656.x     Document Type: Article

References (46)

1. Camins A, Pallas M, Silvestre JS. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find Exp Clin Pharmacol 2008 30 : 43 65.
2. Barzilai A, Biton S, Shiloh Y. The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amst) 2008 7 : 1010 1027.
3. Brasnjevic I, Hof PR, Steinbusch HW, Schmitz C. Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst) 2008 7 : 1087 1097.
4. Martin LJ. DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol 2008 67 : 377 387.
5. Weissman L, Jo DG, Sørensen MM, De Souza-Pinto NC et al. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res 2007 35 : 5545 5555.
6. Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 2000 18 : 433 437.
7. Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith MA. Oxidative damage in Alzheimer's disease: the metabolic dimension. Int J Dev Neurosci 2000 18 : 417 421.
8. Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L et al. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 2004 41 : 549 561.
9. Anisimov VN, Popovich IG, Zabezhinski MA et al. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006 1757 : 573 589.
10. Camins A, Verdaguer E, Folch J et al. Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis. Curr Drug Metab 2007 8 : 709 715.
11. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005 9 : 59 71.
12. Fotuhi M, Zandi PP, Hayden KM et al. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimers Dement 2008 4 : 223 227.
13. Rodríguez MI, Escames G, López LC et al. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 2008 43 : 749 756.
14. Bondy SC, Sharman EH. Melatonin and the aging brain. Neurochem Int 2007 50 : 571 580.
15. Reiter RJ, Paredes SD, Korkmaz A, Jou MJ, Tan DX. Melatonin combats molecular terrorism at the mitochondrial level. Interdisc Toxicol 2008 1 : 137 149.
16. Sharma R, Mcmillan CR, Niles LP. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J Pineal Res 2007 43 : 245 254.
17. Caballero B, Vega-Naredo I, Sierra V et al. Favourable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice. J Pineal Res 2008 45 : 302 311.
18. Chetsawang J, Govitrapong P, Chetsawang B. Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells. J Pineal Res 2007 43 : 115 120.
19. Matsubara E, Bryant-Thomas T, Pacheco Quinto J et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 2003 85 : 1101 1108.
20. Sliwinski T, Rozej W, Morawiec-Bajda A, Morawiec Z, Reiter RJ, Blasiak J. Protective action of melatonin against oxidative DNA damage: chemical inactivation versus base-excision repair. Mutat Res 2007 634 : 220 227.
21. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 2005 38 : 145 152.
22. Lahiri DK, Chen D, Ge YW, Bondy SC, Sharman EH. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res 2004 36 : 224 231.
23. Sharman EH, Sharman KG, Ge YW, Lahiri DK, Bondy SC. Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin. J Pineal Res 2004 36 : 165 170.
24. Lin CH, Huang JY, Ching CH, Chuang JI. Melatonin reduces neuronal loss, down regulation of dopamine transporter, and up regulation of D2 receptor in rotenone-induced parkinsonian rats. J Pineal Res 2008 44 : 205 213.
25. Reynolds J, Logan A, Berry M, Dent RG, Gonzales AM, Toescu EC. Age-dependent changes in Fibroblast growth factor 2 (FGF-2) expression in mouse cerebellar neurons. J Cell Mol Med 2005 9 : 398 406.
26. Toescu EC, Xiong J. Metabolic substrates of neuronal aging. Ann N Y Acad Sci 2004 1019 : 19 23.
27. Xiong J, Camello PJ, Verkhratsky A, Toescu EC. Mitochondrial polarisation status and [Ca2+]i signalling in rat cerebellar granule neurones aged in vitro. Neurobiol Aging 2004 25 : 349 359.
28. 2+ homeostasis in aged cerebellar granule neurons in brain slices. J Neurosci 2002 22 : 10761 10771.
29. Toescu EC, Verkhratsky A. Neuronal ageing in long-term cultures: alterations of Ca2+ homeostasis. Neuroreport 2000 11 : 3725 3729.
30. Alvira D, Yeste-Velasco M, Folch J, Casadesús G et al. Neuroprotective effects of caffeine against complex I inhibition-induced apoptosis are mediated by inhibition of the Atm/p53/E2F-1 path in cerebellar granule neurons. J Neurosci Res 2007 85 : 3079 3088.
31. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang DM. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 1996 66 : 928 935.
32. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998 53 : 701 707.
33. Mason RP, Leeds PR, Jacob RF, Hough CJ et al. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem 1999 72 : 1448 1456.
34. Lee SH, Chun W, Kong PJ, Han JA et al. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J Pineal Res 2006 40 : 79 85.
35. Kilic U, Kilic E, Reiter RJ, Bassetti CL, Hermann DM. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 2005 38 : 67 71.
36. Feng Z, Qin C, Chang Y, Zhang JT. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Free Radic Biol Med 2006 40 : 101 109.
37. Gutierrez-Cuesta J, Sureda FX et al. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J Pineal Res 2007 42 : 394 402.
38. Sureda FX, Gutierrez-Cuesta J, Romeu M, Mulero M et al. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp Gerontol 2006 41 : 360 367.
39. Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J. Alzheimers Dis 2002 4 : 249 254.
40. Kruman II, Schwartz EI. DNA damage response and neuroprotection. Front Biosci 2008 13 : 2504 2515.
41. Woods J, Snape M, Smith MA. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim Biophys Acta 2007 1772 : 503 508.
42. Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 2007 1772 : 494 502.
43. Zhu X, Raina AK, Perry G, Smith MA. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol 2004 3 : 219 226.
44. Webber KM, Raina AK, Marlatt MW et al. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech Ageing Dev 2005 126 : 1019 1025.
45. Hou ST, Callaghan D, Fournier MC, Hill I et al. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 2000 75 : 91 100.
46. O'hare MJ, Hou ST, Morris EJ, Cregan SP et al. Induction and modulation of cerebellar granule neuron death by E2F-1. J Biol Chem 2000 275 : 25358 25364.